| Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing L Ferretti, C Wymant, M Kendall, L Zhao, A Nurtay, L Abeler-Dörner, ... science 368 (6491), eabb6936, 2020 | 3147 | 2020 |
| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1180 | 2021 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 941 | 2022 |
| Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ... The Lancet 397 (10282), 1351-1362, 2021 | 769 | 2021 |
| SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway BJ Willett, J Grove, OA MacLean, C Wilkie, G De Lorenzo, W Furnon, ... Nature microbiology 7 (8), 1161-1179, 2022 | 597 | 2022 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 481 | 2021 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 367 | 2021 |
| SARS-CoV-2 within-host diversity and transmission KA Lythgoe, M Hall, L Ferretti, M de Cesare, G MacIntyre-Cockett, ... Science 372 (6539), eabg0821, 2021 | 364 | 2021 |
| Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom J Wei, N Stoesser, PC Matthews, D Ayoubkhani, R Studley, I Bell, JI Bell, ... Nature microbiology 6 (9), 1140-1149, 2021 | 314 | 2021 |
| The epidemiological impact of the NHS COVID-19 app C Wymant, L Ferretti, D Tsallis, M Charalambides, L Abeler-Dörner, ... Nature 594 (7863), 408-412, 2021 | 294 | 2021 |
| Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 E Alm, EK Broberg, T Connor, EB Hodcroft, AB Komissarov, ... Eurosurveillance 25 (32), 2001410, 2020 | 270 | 2020 |
| OpenABM-Covid19—An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing R Hinch, WJM Probert, A Nurtay, M Kendall, C Wymant, M Hall, K Lythgoe, ... PLoS computational biology 17 (7), e1009146, 2021 | 265 | 2021 |
| Ethics of instantaneous contact tracing using mobile phone apps in the control of the COVID-19 pandemic MJ Parker, C Fraser, L Abeler-Dörner, D Bonsall Journal of Medical Ethics 46 (7), 427-431, 2020 | 257 | 2020 |
| Effective configurations of a digital contact tracing app: a report to NHSX R Hinch, W Probert, A Nurtay, M Kendall, C Wymant, M Hall, K Lythgoe, ... Retrieved July 23, 2020, 2020 | 240 | 2020 |
| An integrated national scale SARS-CoV-2 genomic surveillance network COVID-19 Genomics UK (COG-UK) consortium The Lancet Microbe 1 (3), e99-e100, 2020 | 233 | 2020 |
| A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants M Pizzato, O Erlwein, D Bonsall, S Kaye, D Muir, MO McClure Journal of virological methods 156 (1-2), 1-7, 2009 | 204 | 2009 |
| PHYLOSCANNER: inferring transmission from within-and between-host pathogen genetic diversity C Wymant, M Hall, O Ratmann, D Bonsall, T Golubchik, M de Cesare, ... Molecular biology and evolution 35 (3), 719-733, 2018 | 180 | 2018 |
| Anti-spike antibody response to natural SARS-CoV-2 infection in the general population J Wei, PC Matthews, N Stoesser, T Maddox, L Lorenzi, R Studley, JI Bell, ... Nature communications 12 (1), 6250, 2021 | 145 | 2021 |
| Comparison of next-generation sequencing technologies for comprehensive assessment of full-length hepatitis C viral genomes E Thomson, CLC Ip, A Badhan, MT Christiansen, W Adamson, MA Ansari, ... Journal of clinical microbiology 54 (10), 2470-2484, 2016 | 145 | 2016 |
| Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus MA Ansari, V Pedergnana, C LC Ip, A Magri, A Von Delft, D Bonsall, ... Nature genetics 49 (5), 666-673, 2017 | 137 | 2017 |
